





{"id":636,"date":"2021-02-08T11:15:22","date_gmt":"2021-02-08T10:15:22","guid":{"rendered":"https:\/\/www.degro.org\/ag-stereotaxie\/?page_id=636"},"modified":"2022-08-31T11:11:15","modified_gmt":"2022-08-31T09:11:15","slug":"srs-sbrt-for-metastatic-breast-cancer","status":"publish","type":"page","link":"https:\/\/www.degro.org\/ag-stereotaxie\/projekte\/aktuelle-projekte\/srs-sbrt-for-metastatic-breast-cancer\/","title":{"rendered":"SRS\/SBRT for metastatic breast cancer"},"content":{"rendered":"<div id=\"pl-636\"  class=\"panel-layout\" ><div id=\"pg-636-0\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-636-0-0\"  class=\"panel-grid-cell\" ><div id=\"panel-636-0-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"0\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<h2><strong>Stereotactic radiotherapy (SRS\/SRT\/SBRT) for metastatic breast cancer<\/strong><\/h2>\n<hr \/>\n<h4><span id=\"DeltaPlaceHolderMain\"><strong>Study PI:<\/strong><\/span><\/h4>\n<p>Dr. med. David Krug<br \/>University Hospital Kiel<br \/><a href=\"mailto:david.krug@uksh.de\">david.krug@uksh.de<\/a><\/p>\n<p>PD Dr. Maciana Nona Duma<br \/>Helios Kliniken Schwerin<br \/><a href=\"mailto:marciana.duma@helios-gesundheit.de\">marciana.duma@helios-gesundheit.de<\/a><\/p>\n<h4><strong>Study design: <\/strong><\/h4>\n<p>\u25cf Multicenter, international retrospective study<\/p>\n<h4><strong>Study objective:<\/strong><\/h4>\n<p>\u25cf To analyse the efficacy of SRS\/SRT and SBRT for metastases from breast cancer<\/p>\n<h4><strong>Patient population to be included:<\/strong><\/h4>\n<p>\u25cf Women with metastatic breast cancer and one or more metastases treated with SRS\/SRT\/SBRT; including oligometastatic and polymetastatic disease<strong><br \/><\/strong><\/p>\n<h4><strong>Project plan:<\/strong><\/h4>\n<p>\u25cf Establishment of a retrospective database of patients with breast cancer who received SRS\/SRT\/SBRT to one or more metastatic sites.<br \/>\u25cf Collection of data regarding disease status (synchronous vs. metachronous metastatic disease, oligometastatic vs. polymetastatic oligoprogressive disease)<br \/>\u25cf Collection of data regarding radiotherapy according to ICRU 91 and standard practice for the working group<br \/>\u25cf Collection of data regarding biological subtype (ER\/PR\/HER2-status, grading)<br \/>\u25cf Collection of data regarding systemic therapy (before, during and after stereotactic radiotherapy)<br \/>\u25cf Endpoints: local control, progression-free survival, overall survival, acute (\u2264 90 days from radiotherapy) and chronic (&gt; 90 days from radiotherapy) toxicity<\/p>\n<h4><strong>Project status:<\/strong><\/h4>\n<ul>\n<li>Data collection finalized<\/li>\n<li>Data analysis ongoing<\/li>\n<\/ul>\n<p>\u00a0<\/p>\n<\/div>\n<\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Stereotactic radiotherapy (SRS\/SRT\/SBRT) for metastatic breast cancerStudy PI:Dr. med. David KrugUniversity Hospital Kieldavid.krug@uksh.dePD Dr. Maciana Nona DumaHelios Kliniken Schwerinmarciana.duma@helios-gesundheit.deStudy design: \u25cf Multicenter, international retrospective studyStudy objective:\u25cf To analyse the efficacy of SRS\/SRT and SBRT for metastases from breast cancerPatient population &hellip; <\/p>\n","protected":false},"author":8,"featured_media":0,"parent":77,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-636","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.degro.org\/ag-stereotaxie\/wp-json\/wp\/v2\/pages\/636","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.degro.org\/ag-stereotaxie\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.degro.org\/ag-stereotaxie\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.degro.org\/ag-stereotaxie\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.degro.org\/ag-stereotaxie\/wp-json\/wp\/v2\/comments?post=636"}],"version-history":[{"count":12,"href":"https:\/\/www.degro.org\/ag-stereotaxie\/wp-json\/wp\/v2\/pages\/636\/revisions"}],"predecessor-version":[{"id":840,"href":"https:\/\/www.degro.org\/ag-stereotaxie\/wp-json\/wp\/v2\/pages\/636\/revisions\/840"}],"up":[{"embeddable":true,"href":"https:\/\/www.degro.org\/ag-stereotaxie\/wp-json\/wp\/v2\/pages\/77"}],"wp:attachment":[{"href":"https:\/\/www.degro.org\/ag-stereotaxie\/wp-json\/wp\/v2\/media?parent=636"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}